Healthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valua...
Read article
Switzerland Switzerland Healthcare M&A remains stable. Outpatient models, digitalisation and scale define the next growth phase. Our Q3 update highlights key trends, valua...
Read articleThe contract pharma market is reshaping around scale, specialization, and regulatory trust. Swiss and DACH-based CROs/CDMOs are drawing strong inve...
Read articleDEAL FLASH: The Providence Projects, one of the UK’s leading providers of affordable private alcohol and drug rehabilitation services, has been acq...
Read articleIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Read articleQUARTERLY M&A ACTIVITY: In Q1 2025, Oaklins facilitated 59 transactions across a variety of sectors, driving growth amid economic complexities, wit...
Read articleQUARTERLY M&A ACTIVITY: In 2024's Q4, Oaklins completed 90 M&A transactions, with TMT and Healthcare leading, reflecting innovation and strategic g...
Read articleDEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led ...
Read articleIn our MedTech M&A-Report, you will find updates on M&A activities and company valuations, current trends and an outlook on upcoming developments i...
Read articleQUARTERLY M&A ACTIVITY: From securing growth capital to finding future partners, Oaklins' Q3 deals reflect strategic navigation in dynamic industry...
Read articleDEAL FLASH: AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to...
Read articleQUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the a...
Read articleQUARTERLY M&A ACTIVITY: Q1 saw a dynamic market with significant M&A activity in various industries, with TMT leading with 15 deals. Energy, Real E...
Read articleQUARTERLY M&A ACTIVITY: Oaklins has proven its adaptability and strategic acumen in a challenging market, completing 87 transactions in Q4 and clim...
Read articleJULY AND AUGUST M&A ACTIVITY: We successfully concluded 38 transactions, of which the majority were sell-side. Notably, over 75% of the transaction...
Read articleARTIFICIAL INTELLIGENCE WEBINAR
Read articleMAY DEAL ACTIVITY: Amidst challenging market conditions, Oaklins sees M&A as a vital corporate strategy to build resilience and outperform competit...
Read articleDEAL FLASH: Oaklins’ team in the Netherlands acted as the exclusive M&A sell-side advisor to the shareholders of DierenDokters. This transaction em...
Read articleFEBRUARY DEAL ACTIVITY: Our activity followed a similar pace to what we saw in the first month of 2023 with 14 transactions closed, of which 13 wer...
Read articleJANUARY DEAL ACTIVITY: As we look to build on our 35+-year track record of helping clients navigate complex market conditions, January 2023 saw us ...
Read articleDEAL FLASH: The acquisition of MBI Healthcare Technologies by DNV AS demonstrates Oaklins’ ability to advise on complex international transactions ...
Read articleSUMMER DEAL ACTIVITY: The ongoing economic turmoil is impacting M&A markets but the appetite for M&A persists with 37 transactions closed in July a...
Read articleDEAL FLASH: The acquisition of Silverlink PCS Software Limited provides Alcidion Group Limited with a PAS capability, which is the foundational dat...
Read articleMONTHLY DEAL ACTIVITY: 2022 has got off to a good start for Oaklins with 36 closed transactions of which 34 were M&A deals and two were fundraising...
Read articleMONTHLY DEAL ACTIVITY: In November 2021, we closed 40 transactions of which 31 were M&A deals and 9 were fundraising deals. The surge in deal activ...
Read article